Rectal cancer originates in the rectum (the last inches of the intestinal tract) and is commonly marked by symptoms such as unintended weight loss, extreme fatigue, rectal bleeding, and variations in appetite and frequency. It frequently begins in small clumps known as polyps, most commonly benign, that may develop into cancer overtime. Although its cause is unknown, smoking, inflammatory bowel disease, an inactive lifestyle, a high-fat and low-fiber diet, as well as old age are common risk factors for rectal cancer. Treatments for rectal cancer include surgery, chemotherapy, and radiation therapy. In stage II rectal cancer, the stage can be divided into three: IIA, IIB, and IIC. In IIA, the cancer has grown through the muscularis propria into the pericolorectal tissues. In IIB, the cancer has invaded the surface of the visceral peritoneum. In IIC, the tumor has grown to, or is connected to, other organs or structures. However, in all of these cases, the cancer has not metastasized on any regional or distant lymph nodes or organs.
Stage Ii Rectal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Ii Rectal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 587 products for the study of Stage Ii Rectal Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.